Textbook outcome as indicator of surgical quality in a single Western center: results from 300 consecutive gastrectomies
- PMID: 38145422
- DOI: 10.1007/s13304-023-01727-w
Textbook outcome as indicator of surgical quality in a single Western center: results from 300 consecutive gastrectomies
Abstract
Textbook outcome (TO) has been proposed as a tool to evaluate surgical quality. Textbook oncological outcome (TOO) adds chemotherapeutic compliance to TO. This study was conducted to analyze the TO and TOO of patients with gastric adenocarcinoma who underwent surgery at our center. Data from a prospective database of patients operated on for gastric adenocarcinoma between September 2018 and September 2022 were analyzed. Postoperative management followed Enhanced Recovery After Surgery guidelines. The Dutch Upper Gastrointestinal Cancer Audit group defined TO as a multidimensional measure (10 items). TOO also considers guideline-accordant chemotherapeutic compliance. Three hundred patients underwent surgery during the study period (167 men, 133 women). One hundred seventy-six (58.7%) reached TO. Achieving TO was influenced by patients' comorbidities, calculated via the Charlson Comorbidity Score (3 vs. 4; p = 0.002) and surgery type (subtotal gastrectomy; p < 0.001), but not by the American Society of Anesthesiologists (ASA) score (p = 0.057) or surgical approach (laparoscopic vs. open; p = 0.208). The analysis of TOO included 213 patients. Of these, 71 (33%) underwent complete adequate systemic treatment. Compared with the non-TOO group, patients who achieved TOO had a lower median age (64 vs. 73 years; p < 0.001) and lower ASA score (p < 0.001) and more frequently underwent preoperative chemotherapy (p < 0.001). Our results represent the experience of a single team at a high-volume Western institute. Patients' comorbidities and surgery type influenced whether TO was achieved. Conversely, younger age, lower ASA score and preoperative chemotherapy were associated with TOO.
Keywords: Enhanced recovery after surgery; Gastrectomy; Gastric cancer; Postoperative complications; Textbook.
© 2023. Italian Society of Surgery (SIC).
Similar articles
-
[Safety of double and a half layered esophagojejunal anastomosis in radical gastrectomy: A prospective, multi-center, single arm trial].Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Oct 25;26(10):977-985. doi: 10.3760/cma.j.cn441530-20230301-00058. Zhonghua Wei Chang Wai Ke Za Zhi. 2023. PMID: 37849269 Chinese.
-
Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.Eur J Surg Oncol. 2024 Jun;50(6):108280. doi: 10.1016/j.ejso.2024.108280. Epub 2024 Mar 21. Eur J Surg Oncol. 2024. PMID: 38537365
-
Laparoscopic gastrectomy for treatment of advanced gastric cancer: preliminary experience on 38 cases.Minerva Chir. 2009 Oct;64(5):445-56. Minerva Chir. 2009. PMID: 19859035
-
Impact of Minimally Invasive Approach on Attainment of a Textbook Oncologic Outcome Following Gastrectomy for Gastric Cancer: A Review of the National Cancer Database.Am Surg. 2024 Apr;90(4):819-828. doi: 10.1177/00031348231212587. Epub 2023 Nov 6. Am Surg. 2024. PMID: 37931215 Review.
-
Impact of Textbook Oncologic Outcome Attainment on Survival After Gastrectomy: A Review of the National Cancer Database.Ann Surg Oncol. 2022 Dec;29(13):8239-8248. doi: 10.1245/s10434-022-12388-1. Epub 2022 Aug 16. Ann Surg Oncol. 2022. PMID: 35974232 Review.
Cited by
-
Textbook Outcome of Delta-Shaped Anastomosis in Minimally Invasive Distal Gastrectomy for Gastric Cancer in 4,505 Consecutive Patients.J Gastric Cancer. 2024 Jul;24(3):341-352. doi: 10.5230/jgc.2024.24.e29. J Gastric Cancer. 2024. PMID: 38960892 Free PMC article.
References
-
- Korea S, Bang Y-J, Bang Y-J et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697. https://doi.org/10.1016/S0140 - DOI
-
- Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer from the departments of medicine (D)
-
- Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957. https://doi.org/10.1016/S0140-6736(18)32557-1 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical